CRISTINA NAGY: Open Payments
NPI 1336827500 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 11 payments from 7 companies in 2025. Trend: 2023 $145 · 2024 $522 · 2025 $654
Food & beverage: $351Travel & lodging: $303
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $338 |
| Novo Nordisk Inc | 1 | $124 |
| United Therapeutics Corporation | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $34 |
| CVRx, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Wegovy, Kerendia, OPSYNVI, Barostim Neo System, Remodulin, Tyvaso, Orenitram, JARDIANCE.
Industry payments across FL — which companies pay providers there.
